We report here the hormonal, metabolic and gonadal responses to the glucagon-like peptide-1 (GLP1)-based multi-agonists, GLP1/Estrogen (GLP1/E), GLP1/gastric inhibitory peptide (GLP1/GIP) and GLP1/GIP/Glucagon, in two mouse PCOS models, with variable penetrance of metabolic and reproductive traits, and their comparison with metformin
GHK and DNA: Resetting the human genome to health
It can also reduce inflammation in the lungs, which is beneficial for conditions like asthma and COPD
But if you want to give it a try, you can move ahead with your discretion, as it poses no threat to your skin and overall health
doi: 10.1007/BF01613129 295
patients on the potential effects of GLP1R agonists on the cardiovascular system